Literature DB >> 21146009

A significant number of women present with palpable breast cancer even with a normal mammogram within 1 year.

Danielle J Haakinson1, Chee-Chee H Stucky, Amylou C Dueck, Richard J Gray, Nabil Wasif, Heidi A Apsey, Barbara Pockaj.   

Abstract

BACKGROUND: Although mammography is the gold standard for breast cancer screening, clinical breast examination (CBE) and self breast examination (SBE) are important adjuncts whose utility has been questioned.
METHODS: A retrospective review of invasive breast cancer patients from 2000 to 2008 was performed. We compared 3 groups: breast cancer detected by (1) imaging only (nonpalpable) or palpable mass with a normal mammogram (2) ≥ 1 year (mammogram ≥ 1 year) or (3) <1 year (mammogram <1 year).
RESULTS: Of 1,222 women, presentation included 67% nonpalpable, 21% mammogram ≥ 1 year, and 13% mammogram <1 year. Patients presenting with palpable masses on SBE or CBE even with a normal mammogram within 1 year tended to have more aggressive tumors (larger size, lymph node positive, and triple-negative disease) resulting in more aggressive therapy (a higher mastectomy rate and a greater likelihood of chemotherapy).
CONCLUSION: A significant number of women present with palpable breast cancer within 1 year of a normal mammogram, many with an aggressive cancer. Therefore, we continue to advocate SBE and CBE for breast cancer screening.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21146009     DOI: 10.1016/j.amjsurg.2010.08.005

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  8 in total

1.  The clinical breast exam: a skill that should not be abandoned.

Authors:  Teresa Bryan; Erin Snyder
Journal:  J Gen Intern Med       Date:  2013-05       Impact factor: 5.128

Review 2.  Update of the American Society of Breast Surgeons Toolbox to address the lumpectomy reoperation epidemic.

Authors:  Maureen P McEvoy; Jeffrey Landercasper; Himani R Naik; Sheldon Feldman
Journal:  Gland Surg       Date:  2018-12

3.  Is clinical breast examination important for breast cancer detection?

Authors:  L Provencher; J C Hogue; C Desbiens; B Poirier; E Poirier; D Boudreau; M Joyal; C Diorio; N Duchesne; J Chiquette
Journal:  Curr Oncol       Date:  2016-08-12       Impact factor: 3.677

4.  Presentation of self-detected breast mass in minority women with limited access to care: Can self-examination assist in early cancer detection?

Authors:  Zi Zhang; Ramya Rao; Victoria L Mango; Priscilla Wilson-Gardner; Soumya Vempalle; Oreoluwa Ojutiku
Journal:  Clin Imaging       Date:  2020-10-24       Impact factor: 1.605

5.  Could screening participation bias symptom interpretation? An interview study on women's interpretations of and responses to cancer symptoms between mammography screening rounds.

Authors:  Marit Solbjør; John-Arne Skolbekken; Ann Rudinow Sætnan; Anne Irene Hagen; Siri Forsmo
Journal:  BMJ Open       Date:  2012-11-12       Impact factor: 2.692

Review 6.  Over-reassurance and undersupport after a 'false alarm': a systematic review of the impact on subsequent cancer symptom attribution and help seeking.

Authors:  Cristina Renzi; Katriina L Whitaker; Jane Wardle
Journal:  BMJ Open       Date:  2015-02-04       Impact factor: 2.692

7.  Unintended consequences of an 'all-clear' diagnosis for potential cancer symptoms: a nested qualitative interview study with primary care patients.

Authors:  Cristina Renzi; Katriina L Whitaker; Kelly Winstanley; Susanne Cromme; Jane Wardle
Journal:  Br J Gen Pract       Date:  2016-02-07       Impact factor: 5.386

8.  Time to Treatment Initiation for Breast Cancer During the 2020 COVID-19 Pandemic.

Authors:  Kathryn Hawrot; Lawrence N Shulman; Ira J Bleiweiss; Elizabeth J Wilkie; Zachary A K Frosch; Rachel C Jankowitz; Amy I Laughlin
Journal:  JCO Oncol Pract       Date:  2021-03-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.